News

Allstate Completes Sale of Group Health Business to Nationwide

Allstate Completes Sale of Group Health Business to Nationwide

Allstate Sells Group Health Business to Nationwide

The Allstate Corporation (NYSE: ALL) has officially announced a significant decision in its corporate strategy—selling its Group Health business to Nationwide for an impressive $1.25 billion in cash. This transaction is based on the adjusted closing balance sheet and conforms to standard closing conditions, including necessary regulatory approvals.

Financial Impact of the Sale

For the first three quarters of the year, Allstate’s Group Health unit generated substantial revenues of $608 million, complemented by an Adjusted Net Income of $69 million. This sale not only represents a significant financial maneuver but also aligns with Allstate's ongoing strategy to maximize shareholder value.

Combined Sales Total

Tom Wilson, the Chair, President, and CEO of Allstate, remarked on this milestone, indicating that the Group Health division offers stop-loss insurance targeted at small businesses. This acquisition by Nationwide allows for an expanded portfolio of complementary product offerings. When we consider the previously announced transaction involving the sale of Employer Voluntary Benefits to StanCorp Financial Group, the overall sale proceeds are projected to reach $3.25 billion.

Strategic Objectives and Future Moves

In light of this transaction, the future of Allstate's Individual Health business remains uncertain. This segment reported an Adjusted Net Income of $18 million for the first nine months of the year and will either be retained or merged with a prospective partner.

Nationwide's Growth Through Acquisition

Jess Merten, Allstate’s Chief Financial Officer, elaborated on the benefits Nationwide stands to gain from this acquisition. He noted that the organization is capitalized well and this purchase would support its growth objectives while enhancing product portfolio and distribution capabilities. Notably, Allstate acquired the Group Health business as part of a larger $4.0 billion transaction involving National General just a few years prior.

Advisors for the Transaction

As part of this transition, Allstate has enlisted J.P. Morgan and Ardea Partners to provide financial advisory services, while Willkie Farr & Gallagher LLP is acting as the legal advisor. Concurrently, Nationwide has secured the services of Citi for financial advisement alongside Squire Patton Boggs LLP for legal matters.

About Allstate

The Allstate Corporation (NYSE: ALL) is recognized for safeguarding individuals against life’s uncertainties, providing robust protection across various domains including automobiles, homes, electronic devices, and identity theft. The company operates through an extensive distribution network that includes dedicated Allstate agents, independent agents, and major retailers, along with online services and workplace offerings. Known for its iconic slogan, 'You’re in Good Hands with Allstate,' the corporation continues to strive for excellence in customer service.

About Nationwide

Nationwide is a prominent Fortune 100 organization situated in Columbus. As one of the most substantial and diversified insurance and financial services firms in the United States, it holds an impressive A+ rating from Standard & Poor’s. Nationwide excels in customer-centered innovation, offering an extensive range of services including auto, business, homeowners, life insurance, as well as retirement plans, annuities, and mutual funds. Their commitment also extends to specialty insurance lines for pets, motorcycles, and boats.

Frequently Asked Questions

What is the value of the transaction between Allstate and Nationwide?

The transaction is valued at $1.25 billion in cash, adjusted for the closing balance sheet.

How much revenue did Allstate's Group Health business generate?

For the first nine months of the current fiscal year, the Group Health segment reported revenues of $608 million.

What does this sale mean for Allstate's business strategy?

This sale is a strategic move aimed at maximizing shareholder value while realigning Allstate's health and benefits business with partners that have a better fit in the marketplace.

Who advised Allstate on this sale?

Allstate engaged J.P. Morgan and Ardea Partners as financial advisors, with legal counsel provided by Willkie Farr & Gallagher LLP.

What is the outlook for Allstate's Individual Health business?

The future of the Individual Health business has yet to be determined, with options including retention or a potential merger with another entity.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 303

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 421

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
News Articles